Biotech & Platform Companies
Integrate precise protein conjugation, labelling or immobilization into your platform
What we offer
- An enzymatic method for site-specific protein conjugation and labelling, with applications in detection and immobilization.
- Scientific support to evaluate Connectase with your constructs, assay conditions and platform requirements.
- Evaluation kits and flexible collaboration models, from proof of concept to joint development, supply or licensing.
How we work together
- We discuss your platform, intended application and performance requirements.
- We agree on an evaluation plan, carried out by your team, ours or jointly.
- Where needed, we adapt the workflow or format together and assess performance in your system.
- We define a supply, licensing or co-development arrangement that fits your platform and commercial plans.
Learn more
More on working with biotech and platform companies
Whether you are developing analytical assays, diagnostic systems, protein engineering tools or new therapeutic platforms, Connectase offers a precise enzymatic method for protein detection, conjugation and immobilization.
Applications include the preparation of defined antibody-drug conjugates (ADCs), functionalization of virus-like particles (VLPs) and lipid nanoparticles (LNPs), and immobilization of functional proteins and enzymes on surfaces or materials. Our technology can be integrated into existing workflows or incorporated into new product designs.
We also see opportunities in industrial biotechnology, where robust enzyme attachment can support process optimization and reuse. We work with partners to evaluate Connectase in their specific applications and develop practical approaches to integration, supply and commercialization.